Two doses of Pfizer's COVID-19 vaccine adjusted in potency for children 5 to 11 years old proved 90.7% effective against ...
The analysis was posted late Friday ahead of a meeting of the agency's vaccine advisers to discuss the benefits and risks of ...
Pfizer Inc. said the Covid-19 shot it developed with BioNTech SE was 90.7% effective against symptomatic cases in children ...
Agency reviewers stopped short of calling for Pfizer’s shot to be authorized. The agency will put that question to a panel of ...
The COVID vaccine dose made by Pfizer and its partner BioNTech for kids ages 5 to 11 is safe and highly effective, according ...
Two doses of Pfizer's COVID-19 vaccine adjusted in potency for children 5 to 11 years old proved 90.7% effective against ...
If the vaccine is granted an emergency use authorization, which would likely come in early November, it would open up shots ...
In a new document posted ahead of a key meeting of the US Food and Drug Administration’s vaccine advisers, Pfizer says its ...
The companies studied a 10 microgram vaccine dose in children 5 to 11, a third of the dose used for adults, to minimize side ...
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- ...
Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- ...